Advantage Generics is rooted in the convergence of the real world and the virtual, which coincides with the blurring roles of the research-based pharma companies and the generic houses, as companies on both sides of the industry divide finally come to realise the benefits of a mixed portfolio. The fragmentation of media, significance of social networks and the virtual lifestyles adopted by the online generation are just and indication of bigger things to come.
The world's Industry leaders are those who thought ahead of the game to surpass the industry giants of yesterday, leaving the historic leaders struggling to catch up.
Advantage Generics will be a virtual platform for one pharmaceutical player to leverage and step 'ahead of the game'. The generics market is highly price sensitive and thus yields insufficient margins for extensive brand building.
The Advantage Generics platform by passes the costs involved in global brand building and enables unprecedented market share in the low margin generics market.
Exclusivity is not available to all. Advantage Generics will propel one pharmaceutical company leaving the competition behind.